Scholl Hendrik Peter 4
4 · BELITE BIO, INC · Filed Jun 17, 2026
Research Summary
AI-generated summary of this filing
Belite Bio (BLTE) CMO Hendrik P. Scholl Sells Shares
What Happened
Hendrik P. Scholl, Chief Medical Officer of Belite Bio, sold a total of 10,000 American Depositary Shares (ADSs) in multiple open-market transactions on June 16, 2026, generating approximately $1,405,729 in proceeds. The individual disposals were: 2,054 @ $137.61 ($282,641); 784 @ $138.18 ($108,331); 3,140 @ $139.57 ($438,260); 540 @ $140.58 ($75,915); 100 @ $141.83 ($14,183); 450 @ $142.20 ($63,988); 1,897 @ $143.55 ($272,314); and 1,035 @ $145.02 ($150,097). All transactions are reported as sales (code S).
Key Details
- Transaction date: June 16, 2026; Form 4 filed June 17, 2026 (timely filing).
- Prices ranged roughly from $137.19 to $145.60 (footnotes give weighted-average group ranges for the executed trades).
- Total shares sold: 10,000 ADSs; total proceeds: ~$1.406M.
- Each ADS represents one ordinary share of the issuer (footnote F1).
- Footnotes F2–F8 indicate weighted-average prices and price ranges for grouped sales and offer to provide per-price breakdowns on request.
- The filing does not disclose shares owned by Scholl after these transactions in the summary information provided here.
Context
These were open-market dispositions (sales). Sales by executives can be routine (e.g., diversification or liquidity) but do not by themselves indicate company performance; no purchase, option exercise, gift, or 10b5-1 plan is reported in the provided details.
Insider Transaction Report
- Sale
American depositary share
[F1][F2]2026-06-16$137.61/sh−2,054$282,641→ 32,946 total(indirect: By Bioptima Ltd.) - Sale
American depositary share
[F1][F3]2026-06-16$138.18/sh−784$108,331→ 32,162 total(indirect: By Bioptima Ltd.) - Sale
American depositary share
[F1][F4]2026-06-16$139.57/sh−3,140$438,260→ 29,022 total(indirect: By Bioptima Ltd.) - Sale
American depositary share
[F1][F5]2026-06-16$140.58/sh−540$75,915→ 28,482 total(indirect: By Bioptima Ltd.) - Sale
American depositary share
[F1]2026-06-16$141.83/sh−100$14,183→ 28,382 total(indirect: By Bioptima Ltd.) - Sale
American depositary share
[F1][F6]2026-06-16$142.20/sh−450$63,988→ 27,932 total(indirect: By Bioptima Ltd.) - Sale
American depositary share
[F1][F7]2026-06-16$143.55/sh−1,897$272,314→ 26,035 total(indirect: By Bioptima Ltd.) - Sale
American depositary share
[F1][F8]2026-06-16$145.02/sh−1,035$150,097→ 25,000 total(indirect: By Bioptima Ltd.)
Footnotes (8)
- [F1]Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer.
- [F2]Represents the weighted average price of shares sold at prices that ranged from $137.19 to $137.9. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average price of shares sold at prices that ranged from $138 to $138.74. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F4]Represents the weighted average price of shares sold at prices that ranged from $139.01 to $139.9575. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F5]Represents the weighted average price of shares sold at prices that ranged from $140.325 to $140.825. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F6]Represents the weighted average price of shares sold at prices that ranged from $142.14 to $142.24. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F7]Represents the weighted average price of shares sold at prices that ranged from $143.035 to $143.915. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F8]Represents the weighted average price of shares sold at prices that ranged from $145.02 to $145.6. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.